Bio-Rad and Caliper plan miniature laboratory products:
This article was originally published in Clinica
Bio-Rad Laboratories and Caliper Technologies are to develop and market a new microfluidics system. The deal centres on Mountain View, California-based Caliper's LabChip technology, which miniaturises and accelerates tests which can require large pieces of laboratory equipment, automating and integrating them into a chip-based process. Bio-Rad, of Hercules, California, will provide R&D funding, as well as acting as exclusive manufacturer of the devices, and will pay royalties on sales of software and instruments. The deal gives Caliper access to Bio-Rad's 70,000 clinical diagnostics and life science research customers.
You may also be interested in...
COVID-19 Vaccines: ACIP’s Allocation Proposal Prioritizes Long-Term Care Residents, Essential Workers
First group to receive vaccine would comprise health care personnel and residents of long-term care facilities; next in line are non-health care essential workers, who would take priority over adults with high-risk medical conditions and those ages 65 years and older, according to the CDC advisory committee’s proposed allocation framework.
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.